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Ipse, a urogenital parasite-
derived immunomodulatory 
protein, ameliorates ifosfamide-
induced hemorrhagic cystitis 
through downregulation of pro-
inflammatory pathways
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Ifosfamide and other oxazaphosphorines can result in hemorrhagic cystitis, a constellation of 
complications caused by acrolein metabolites. We previously showed that a single dose of Ipse 
(Interleukin-4-inducing principle from Schistosoma eggs), a schistosome-derived host modulatory 
protein, can ameliorate ifosfamide-related cystitis; however, the mechanisms underlying this 
urotoxicity and its prevention are not fully understood. to provide insights into Ipse’s protective 
mechanism, we undertook transcriptional profiling of bladders from ifosfamide-treated mice, 
with or without pretreatment with Ipse or Ipse-NLs (a mutant of Ipse lacking nuclear localization 
sequence). Ifosfamide treatment upregulated a range of proinflammatory genes. The IL-1β-
tNFα-IL-6 proinflammatory cascade via NFκB and STAT3 pathways was identified as the key driver 
of inflammation. The NRF2-mediated oxidative stress response pathway, which regulates heme 
homoeostasis and expression of antioxidant enzymes, was highly activated. Anti-inflammatory 
cascades, namely Wnt, Hedgehog and PPAR pathways, were downregulated. IPSE drove significant 
downregulation of major proinflammatory pathways including the IL-1β-tNFα-IL-6 pathways, 
interferon signaling, and reduction in oxidative stress. IPSE-NLS reduced inflammation but not 
oxidative stress. Taken together, we have identified signatures of acute-phase inflammation and 
oxidative stress in ifosfamide-injured bladder, which are reversed by pretreatment with Ipse. this 
work revealed several pathways that could be therapeutically targeted to prevent ifosfamide-induced 
hemorrhagic cystitis.
Hemorrhagic cystitis is a serious and difficult to manage complication resulting from exposure to certain chem-
otherapeutic agents1, radiation therapy2 and various viruses in immunosuppressed patients3,4. Indeed, anticancer 
doses of oxazaphosphorines, such as cyclophosphamide and ifosfamide, are limited in part due to the risks of this 
complication1. In the case of these agents, hepatic drug metabolism generates toxic acrolein which accumulates 
in bladder urine5. Fortunately, risks of chemotherapy-induced hemorrhagic cystitis have been decreased through 
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the use of 2-mercaptoethane sulfonate Na (MESNA), which directly binds and neutralizes acrolein6,7. However, 
MESNA fails to treat established hemorrhagic cystitis6,7 and can also produce its own adverse reactions8,9. Other 
treatment options, including intravesically administered drugs10,11, systemically administered agents6,12, and non-
pharmacological interventions13,14, are either investigational or feature significant potential side effects5,15.
The mechanisms underlying the initiation and pathogenesis of the acrolein-induced urotoxic effect are 
only partially elucidated. Knowledge gained from various studies and as reviewed by Haldar et al.5 has impli-
cated pro-inflammatory, heme homeostasis, and oxidative stress response pathways in the pathogenesis of 
acrolein-triggered bladder damage. Accumulation of acrolein-containing urine in the bladder lumen depletes 
the mucosal glycosaminoglycan layer and the asymmetric unit membrane (uroplakin complex), exposing the 
urothelium. Acrolein induces pyroptosis in the urothelium, a highly inflammatory form of apoptosis. The result-
ing sloughing and denudation of the urothelial layer exposes the lamina propria, detrusor muscle, and the bladder 
vasculature to further damage5. Acrolein catalyzes reactions that generate reactive oxygen and nitrogen spe-
cies (ROS and RNS) and superoxide radicals in the urothelium, resulting in membrane damage, DNA dam-
age and cell death via the NFκB pathway16,17. The activation and involvement of the inflammasomes complex 
in response to this oxidative stress results in the maturation and release of IL-1β, which in turn orchestrates a 
pro-inflammatory microenvironment in the urothelium18. This stress state also stimulates innate immune pattern 
recognition receptors (TLRs, NLRS and CLRs), sending signals that activate the NFκB, STAT3, MAPK and other 
pro-inflammatory pathways, which lead to transcription of several pro-inflammatory cytokines (IL-1β, TNFα 
and IL-6), pro-inflammatory mediators (iNOS and COX-2) and chemokines that promote leukocyte infiltration 
and further drive inflammation and oxidative stress18,19. In response to hemorrhage from damaged blood vessels 
and accumulating superoxide radicals, the heme homeostasis pathway and the oxidative stress response pathways 
are fully activated via NRF2-mediated mechanisms20. The clotting, edema and constriction of the bladder results 
in hyperalgesia.
There is a significant need for additional approaches to prevent and treat chemotherapy-induced hemor-
rhagic cystitis. Some analogs of cyclophosphamide that may enhance cytostatic efficacy while limiting urotoxicity 
have been explored, albeit with limited success21,22. Candidate drugs targeting the inflammatory IL-1β, TNFα 
and IL-6 triad18,23 and/or promoting antioxidant responses show promise for ameliorating hemorrhagic cystitis 
but have not progressed beyond preclinical testing. Most efforts have been focused towards finding alternatives 
to MESNA, including anti-inflammatory molecules24–26, hemostatic agents27,28, antioxidants29–31, cytokines12,32, 
platelet rich plasma33, nutritional approaches34, and plant extracts26,35. These early-stage therapeutic candidates 
target pro-inflammatory pathways, heme homeostasis pathway and anti-oxidant homoeostasis.
Another potential approach to treat chemotherapy-induced hemorrhagic cystitis is to administer IL-412, a 
potent anti-inflammatory cytokine known to antagonize the IL-1β, TNFα and IL-6 pathways. This finding led us 
to test and verify that a single dose of an IL-4-inducing, parasite-derived anti-inflammatory molecule (IPSE, the 
IL-4-inducing principle from Schistosoma mansoni eggs) ameliorated the inflammation, hemorrhage, and urothe-
lial sloughing associated with ifosfamide-induced hemorrhagic cystitis24. IPSE binds immunoglobulins, notably 
IgE on the surface of basophils and mast cells, inducing secretion of preformed IL-436. However, we suspect IPSE 
may have additional mechanisms underpinning its ability to alleviate ifosfamide-induced hemorrhagic cystitis. 
IPSE also sequesters chemokines37, which likely orchestrate anti-inflammatory responses. As an infiltrin possess-
ing a nuclear localization sequence (NLS), IPSE is able to translocate into host cell nuclei to modulate host gene 
transcription38. Given that the transcriptional changes during ifosfamide-induced hemorrhagic cystitis are largely 
unknown, and because the underlying mechanisms of IPSE’s protective effects remain to be elucidated, we under-
took transcriptome-wide profiling of the bladder of ifosfamide-treated mice using RNA-Seq. Furthermore, we 
studied the gene expression dynamics in IPSE pretreated mice challenged with ifosfamide. Using a mutant of IPSE 
lacking nuclear localization efficacy, we assessed the effect of the nuclear localization on IPSE therapeutic efficacy. 
Here, we show that key pro-inflammatory, heme homeostatic and oxidative stress response pathways are highly 
activated in the bladder following ifosfamide insult. Finally, we show that IPSE downregulates pro-inflammatory 
responses and contributes to restoring oxidative homeostasis as a potential protective mechanism, in addition to 
its involvement in promoting urothelial repair.
Results
Ifosfamide-induced hemorrhagic cystitis is ameliorated by Ipse. We recently showed that a single 
dose of IPSE was comparable to administration of recombinant IL-4 or three doses of MESNA in alleviating 
ifosfamide-induced hemorrhagic cystitis24. We used these established methods to obtain bladder samples for 
transcriptional profiling. Mice were administered: (1) saline or (2) IPSE, 24 hours before ifosfamide challenge, 
or (3) saline vehicle alone. Twelve hours following ifosfamide insult, bladder histopathology was analyzed in a 
blinded fashion. Compared to bladders from saline-treated mice (Fig. 1A), bladders from mice challenged with 
ifosfamide showed marked edema, dysregulated contraction, hemorrhage, and urothelial sloughing (Fig. 1B,D). 
Conversely, bladders from mice treated with IPSE before ifosfamide challenge were significantly protected from 
urothelial denudation and inflammation (Fig. 1C). Based on blinded scoring of bladder sections, we observed 
significant increases in inflammation (p = 0.0234), (Fig. 1E), urothelial denudation (p = 0.0001), (Fig. 1F), and 
edema (p = 0.0025), (Fig. 1G), and considerable increase in hemorrhage (Fig. 1H) in ifosfamide-treated mice. 
These features were markedly reduced in mice administered a single dose of IPSE before ifosfamide, in compar-
ison to ifosfamide-treated mice. Both inflammation (p = 0.0092), and urothelial denudation (p = 0.0013), were 
significantly reduced (Fig. 1E,F), while edema and hemorrhage were considerable reduced (Fig. 1G,H). Taken 
together, these demonstrate characteristic features of ifosfamide-induced hemorrhagic cystitis, some of which 
were significantly reduced by IPSE pretreatment.
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Transcriptional profiles show massive pro-inflammatory response during ifosfamide-induced 
hemorrhagic cystitis. Ifosfamide is metabolized in the liver to generate acrolein, which accumulates in 
urine and damages the bladder8. To understand the transcriptional alterations elicited by acrolein in the blad-
der during ifosfamide-induced hemorrhagic cystitis, mice were treated with saline vehicle or ifosfamide. Gene 
expression dynamics in the ifosfamide-injured bladder were studied through RNA-Seq performed on bladders 
harvested 6 hours following ifosfamide injection. RNA sequencing was performed to a considerable depth (>20 
million reads), more than 96% of which were successfully aligned to the Mus musculus genome (v. Mm10). 
Principal component analysis indicated gene expression homogeneity among ifosfamide-treated bladders relative 
to the vehicle control (Fig. 2A). Volcano plotting of differentially expressed genes and their associated statistical 
significance (Fig. 2B) revealed upregulation of a large set of genes (n = 2061) and downregulation of an appreci-
able number of genes (n = 1114), based on p-value (adjusted) <0.1 and log2(Fold Change) >1 (at least 2-fold). 
Among the top upregulated genes were Il6, a major member of the IL-1β, TNFα and IL-6 pro-inflammatory 
triad. Indeed, the Il1b, Tnfa and Il6 genes were upregulated by about two orders of magnitude. These three 
cytokines together are major drivers of inflammatory responses. The Ptx3 gene was also one of the top upregu-
lated genes. The pentraxin protein family are major components of the humoral arm of innate immune response 
highly induced in response to inflammatory stimuli39. Chemokines were also highly upregulated, especially Cxcl2 
and Ccl2. The top activated upstream regulator is TNFα (Supplementary Fig. S1). In addition, the Hmox1 gene 
encoding the heme oxygenase 1, the first enzyme of the heme oxygenase pathway, was also highly upregulated. 
The Eid3 gene, also among the most upregulated genes, is involved in cellular responses to stress (Fig. 2B and 
Supplementary Fig. S1). The cysteine transporter, Slc7a11, which has been implicated in glutathione metabolism 
in the bladder40, was also significantly upregulated in ifosfamide-injured bladders (Fig. 2B).
Pathways and functional analyses expectedly revealed signatures of inflammation. Specifically, there was 
differential activity involving the IL-6 pathway, in which IL-1β, TNFα and IL-6 play major roles, and other 
pro-inflammatory pathways implicated in the pathogenesis of ifosfamide-induced hemorrhagic cystitis18,23,41,42 
(Fig. 3 and Supplementary Fig. S1). The expression of Il6 and its cognate receptors were highly upregulated, in 
addition to Stat3 and the tyrosine protein kinase Jak2, which are both involved in IL-6 signaling (Fig. 4A and 
Supplementary Fig. S2A). Similarly, Il1b, Tnfa and their receptors were upregulated. These cascades converge 
through Tak1 to promote formation of the IκB-NFκB complex and drive pro-inflammatory gene transcrip-
tion in conjunction with NF-IL-6, the nuclear factor of IL-6 expression (Fig. 4A and Supplementary Fig. S2B). 
Accordingly, the STAT3 and NFκB pathways, both major drivers of inflammation and immune response via 
the IL-1β-TNFα-IL-6 triad, were upregulated following ifosfamide insult transcription (Supplementary Fig. S2). 
Other major upregulated pro-inflammatory pathways and disease signaling cascades included those related to 
TNF receptors, iNOS, the acute phase response, osteoarthritis, diabetes mellitus, HMGB1, TREM1, oncostatin, 
generation of ROS and RNS, VEGF signaling, IL-8 signaling, leucocyte extravasation signaling and major innate 
Figure 1. IPSE ameliorates ifosfamide-induced hemorrhagic cystitis. Mice were pretreated with saline or IPSE 
24 hours before challenge with 400 mg/kg of ifosfamide. Bladders were assessed for histopathologic changes 
following ifosfamide insult in a blinded fashion. (A) Normal bladder showing intact urothelium with no signs of 
pathology. (B) Bladder from an ifosfamide-treated mouse (pretreated with saline) showing urothelial sloughing 
and edema. (C) Bladder from an IPSE-pretreated, ifosfamide-challenged mouse showing significant reduction 
in inflammation, urothelial denudation and edema. (D) High power view of bladder section shown in dotted 
box in (B). Graphs showing treatment group differences in bladder (E) inflammation, (F) urothelial denudation, 
(G) edema, and (H) hemorrhage. Each symbol represents the score for an individual mouse. Cross bar for each 
group denotes mean score. *p < 0.05, **p < 0.01, ****p < 0.001 based on post-hoc Students t-tests following 
significant difference among groups by ANOVA.
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immune-related cascades (Fig. 3 and Supplementary Fig. S3). Finally, there was noteworthy upregulation of the 
IL-17F-mediated allergic inflammatory signaling pathways (Supplementary Fig. S3).
Transcriptional modulatory effects of IPSE on the ifosfamide-exposed bladder. We recently 
reported that IPSE, an immunomodulatory protein of parasite origin, can ameliorate much of the pathology 
associated with ifosfamide-induced hemorrhagic cystitis24(and Fig. 1). To provide insight into the underlying 
mechanisms of the IPSE’s protective effects, we undertook gene expression profiling of the ifosfamide-challenged 
bladder, with or without IPSE pretreatment. Mice were treated with saline, IPSE or the NLS mutant of IPSE 
(lacking nuclear localization but retaining other functions), 24 hours before challenge with ifosfamide. Gene 
expression dynamics were profiled through RNA-Seq analysis of bladders harvested 6 hours following ifosfamide 
administration. Compared to mice receiving ifosfamide without IPSE pretreatment, genes encoding cytokines 
driving pro-inflammatory responses (Il1b, Tnfa and Il6 triad) were downregulated 50% in the bladders of mice 
treated with IPSE or its NLS mutant before ifosfamide challenge (Figs 4B and 5A). While Il1b (p = 0.0213) and 
Tnfa (p = 0.0007) were significantly downregulated, Il6 was considerably downregulated as well (Fig. 4B). Similar 
downward trends in gene expression were observed for genes encoding these cytokines’ receptors, chemokines 
and downstream transcriptional factors driving inflammation (Fig. 5A). The relationship between Il1b, Tnfa and 
Il6 triad and the downstream regulators and mediators is illustrated in Fig. 5B. Interestingly, the expression of 
Cxcl10 (IP-10), a major interferon gamma-induced chemokine, was highly increased in ifosfamide-injured blad-
ders but downregulated in the bladders of IPSE or its NLS mutant-pretreated, ifosfamide-exposed mice (Fig. 5A). 
The transcriptional levels of several other chemokines also involved in inflammatory responses and recruitment 
of cells to sites of stress were highly upregulated in bladders only exposed to ifosfamide, but conversely downreg-
ulated in ifosfamide-injured bladders pretreated with IPSE or IPSE mutant lacking the nuclear localization func-
tion (Fig. 5A). The predicted mechanistic network of gene interaction grids associated with IPSE administration 
featured a network linking downregulation of Ccl2 (and other chemokines genes) to the downregulation of genes, 
including genes encoding a number of gamma interferon-inducible proteins and nitric oxide synthase (Fig. 5C 
and Supplementary Fig. S4). Other mechanistic networks suggesting IPSE induced downregulation of additional 
pro-inflammatory factors were also noted (Supplementary Fig. S4).
The most downregulated gene pathway (in terms of statistical significance) in the bladders of IPSE-pretreated, 
ifosfamide-exposed mice, compared to bladders exposed only to ifosfamide, was the interferon signaling path-
way (Fig. 6). Many of the major gene pathways noted in Fig. 3 to be highly upregulated in ifosfamide-damaged 
bladders were relatively downregulated in bladders pretreated with IPSE before ifosfamide challenge (Fig. 6). 
Similar profile of downregulation of inflammatory pathways was observed in the bladders of mice pretreated with 
the NLS mutant of IPSE before ifosfamide challenge (Supplementary Fig. S5A). These downregulated pathways 
included those related to interferon signaling, inflammatory diseases such as osteoarthritis and diabetes mellitus, 
Figure 2. RNA-Seq analysis of ifosfamide-exposed bladders indicates multiple inflammation and stress 
response-related genes are differentially regulated. (A) Principal component analysis showed homogeneous 
clustering of gene expression among ifosfamide-treated mice (turquoise symbols labeled with “ifos”) and 
vehicle-treated mice (red symbols labeled with “Sal”). The PCA also showed no overlap of gene expression 
among ifosfamide-treated mice and IPSE-treated mice challenged with ifosfamide (purple symbols labeled with 
“H06”). However, there was overlap of gene expression among IPSE-treated mice and mice treated with the 
mutant of IPSE deficient for the nuclear localization sequence (green symbols labeled with “NLS”) (B) Volcano 
plots demonstrated upregulated and downregulated genes in bladders from ifosfamide-versus saline-treated 
mice. For this comparison, p-value (adjusted) <0.1 and log2(Fold Change) >1 (at least 2-fold) were applied as 
threshold values. NS: genes with non-significant changes in expression levels [black dots].
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pattern recognition receptor signaling pathways of the innate immune system, pro-inflammatory pathways 
including NFκB, iNOS, neuroinflammation, TREM1, the acute phase response, HMGB1, STAT3, IL-6, TNFR, 
IL-1 and pathways involved in the production of ROS and RNS (Fig. 6). We also observed a relative increase in 
metabolic gene expression relevant to oxidative phosphorylation, glycolysis and PPAR signaling. PPAR signaling 
has also been shown to be anti-inflammatory43–45. Interestingly, the most downregulated genes in terms of z-score 
were those related to the neuro-inflammation signaling pathway (astrocytes and microglia). While a direct effect 
of IPSE on bladder neurons could not be inferred based on this finding, due to a lack of astrocytes and microglia 
in the bladder, we have observed significant reduction in bladder pain in IPSE-treated mice challenged with 
ifosfamide24. Head to head comparison of gene expression dynamics from mice pretreated with IPSE and its 
NLS mutant before ifosfamide challenge showed differential upregulation of extracellular matrix related path-
ways, including integrin signaling, ILK (integrin-linked kinase) signaling, actin cytoskeleton signaling, paxillin 
signaling and downregulation of cholesterol biosynthesis pathway (Supplementary Fig. S5B). Although these 
pathways are unrelated to inflammation and oxidative stress, the comparison indicated relative upregulation of 
some inflammation related pathways albeit to a less extent, including leucocyte extravasation signaling, VEGF 
signaling, IL-8 and chemokine signaling, and some chemokine receptor signaling (Supplementary Fig. S5B).
Oxidative stress responses during ifosfamide-induced hemorrhagic cystitis and the effect of 
Ipse. Another hallmark of ifosfamide-induced hemorrhagic cystitis is a significant oxidative stress response 
to acrolein exposure and resulting hemorrhage17. Our data underscores a major role for the erythroid-derived 
leucine zipper NRF2 as a nuclear factor involved in regulating oxidative stress responses to ifosfamide injury of 
the bladder28,29,46 (Figs 3 and 7 and Supplementary Fig. S6). The NRF2-mediated oxidative stress responses path-
way, which regulates the expression of antioxidant and heme homeostatic enzymes, was one of the most upreg-
ulated pathways in the bladder following ifosfamide insult (Fig. 3). We noted considerable upregulation of genes 
encoding enzymes including heme oxygenase (Hmox1), which catalyzes the first step in heme homeostasis, the 
Figure 3. Most differentially altered pathways in the bladder during ifosfamide-induced hemorrhagic cystitis. 
Functional comparison of the transcriptome of bladders from ifosfamide- versus vehicle-treated mice was 
performed using IPA57. Bars are colored according to z-score (predicts activation or inhibition based on 
the degree of overlap between directional expressions from observed data and the QIAGEN-curated public 
knowledge base), with red showing activation and blue denoting inhibition. The size of each bar is proportional 
to its –log(p-value).
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antioxidant thioredoxin reductase (Txnrd1), which catalyzes the reduction of thioredoxin to restore redox home-
ostasis, peroxiredoxin (Prdx1), which detoxifies peroxide radicals, and glutathione reductase (Gsr), which reduces 
glutathione disulfide to glutathione, an important antioxidant that scavenges hydroxyl radicals. Also upregulated 
were thioredoxin (Txn1), superoxide dismutase (Sod) and ferritin heavy chain protein (Fth1), which are involved 
in redox signaling, superoxide partitioning and iron homeostasis, respectively (Fig. 7B). Genes encoding proteins 
involved in xenobiotic detoxification were also upregulated in response to acrolein (Fig. 7B). In addition, the p38 
MAPK pathway, implicated in responses to stress stimuli25, was also substantially upregulated. The antioxidant 
action of Vitamin C pathway was also downregulated.
Compared to bladders exposed only to ifosfamide or pretreated with the NLS mutant of IPSE before ifosfa-
mide, bladders pretreated with IPSE before ifosfamide relatively downregulated gene expression of some anti-
oxidant enzymes, including Abcc1, Gclc, Gclm, Gm3776, Gsr, Gss, Gsta1, Gsta2, Prdx1, Sod2, Stip1, Dnaja1 and 
Dnajb1 (Fig. 7B). It is notable that the downregulated gene expression of proteins in this pathway were mainly 
those involved in DNA damage sensing, glutathione-mediated redox homeostasis, superoxide partitioning and 
detoxification of xenobiotics, and metal ion homeostasis (Fig. 5B). In particular, relatively lower expression of 
genes encoding superoxide dismutase (Sod2) and the ferritin protein (Fth1) suggest relatively earlier restoration 
of iron homeostasis in IPSE pretreated mice, supporting the observed decrease in bladder hemorrhage induced by 
IPSE pretreatment before IFS challenge24. Downregulation of the stress induced protein (Stip1) suggest reduced 
oxidative stress. Downregulation of proteins involved in DNA damage sensing suggest decreased pyroptosis and 
tissue damage. Taken together, these data suggest in IPSE-pretreated bladders exposed to ifosfamide, that there 
is a significant anti-oxidant response following accumulation of acrolein, but lower expression of genes related to 
detoxification of xenobiotics, DNA damage sensing and iron homeostasis suggest earlier restoration of oxidative 
homeostasis compared to the group treated with the NLS mutant of IPSE or ifosfamide only.
other pathways altered during ifosfamide-induced hemorrhagic cystitis. The most downregu-
lated pathway in the ifosfamide-exposed bladder was the peroxisome proliferator-activated receptor (PPAR) sign-
aling pathway, which is involved in lipid homoeostasis47, in addition to its anti-inflammatory effect43,44 and role in 
the development and maintenance of IL-4-dependent alternatively activated status in macrophages45 (Fig. 3 and 
Supplementary Fig. S7). Interestingly, PPAR signaling was relatively increased in IPSE pretreated mice compared 
to mice administered ifosfamide only (Fig. 6). TWEAK signaling, Wnt/β-catenin and Hedgehog signaling, which 
can mediate anti-inflammatory responses, were likewise downregulated in the ifosfamide only group (Fig. 3). The 
aldosterone signaling pathway in epithelial cells, which is involved in ion transport to maintain electrolyte and 
water balance across epithelial surfaces, was also downregulated (Fig. 3). Finally, analysis of diseases and functions 
Figure 4. The IL-1β, TNFα, and IL-6 pathways, a major inflammatory pathway upregulated in the bladder 
during ifosfamide-induced hemorrhagic cystitis was downregulated by IPSE pretreatment. (A) Pathway 
and functional analyses were generated through the use of IPA57. Bladders of ifosfamide-exposed mice 
upregulated expression of genes from the IL-1β, TNFα and IL-6 pathways and their corresponding receptors 
and downstream nuclear transcriptional factors. In the case of IL-1β and TNFα, these cascades converge upon 
NFκB. IL-6 also indirectly interacts with NF𝜅B through ERK1/2 activation of NF-IL6, which works with NFκB 
to promote transcription of target genes. Keys: upregulation (red), downregulation (green), cytokines (square), 
growth factors (dotted square), phosphatase (triangle), kinases (inverted triangle), transmembrane receptors 
(ellipse), transcriptional regulators (wide circle), peptidase (rhombus), group or complex (double lined shapes), 
transporter (trapezium), acts on (line with filled arrow), translocate (line with open arrow), inhibition (line with 
perpendicular line at edge). (B) Il1b, Tnfa, Il6 and Ptx3 gene transcription were upregulated by 2–3 orders of 
magnitude in the bladders of ifosfamide-treated mice. Pretreatment with IPSE or its NLS mutant reduced the 
levels by ~50% relative to the ifosfamide-treated group. Similar trends were observed for cognate receptors and 
downstream transcription factors (data not shown).
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affected by bladder ifosfamide challenge showed considerable upregulation of functions related to organismal 
injury and abnormalities, inflammatory diseases, cancer, cell proliferation, cellular movement and hematological 
development and function (Supplementary Fig. S8). There was also notable upregulation of genes and regulators 
in the neuroinflammatory pathways (Supplementary Fig. S9). Analysis of differentially altered genes in the neu-
roinflammatory pathways indicated significant expression of genes encoding proinflammatory cytokines and 
mediators in the astrocytes, microglia, including their effect on post-synaptic neuron (Supplementary Fig. S9). 
Conversely, there was downregulation of the neuroinflammatory cascades in the IPSE pretreated group (Fig. 6), 
in addition to our previous observation of IPSE-induced reduction in ifosfamide-related bladder pain24. Although 
this may suggest an ameliorative role for IPSE in the acrolein-associated hyperalgesia, the presence of astro-
cytes or microglia in the peripheral nervous system within the bladder is unlikely. Finally, HIF-1α-mediated 
hypoxia-related signaling cascade was upregulated in the bladder after ifosfamide insult, consistent with the hem-
orrhage associated with hemorrhagic cystitis (Supplementary Fig. S10).
Discussion
Herein we describe the first transcriptome-wide profiling of the bladder during ifosfamide-induced hemorrhagic 
cystitis. To accomplish this, we used a tractable mouse model which recapitulates the pathogenesis of hemor-
rhagic cystitis12 resulting from the urotoxic effect of acrolein, a byproduct of ifosfamide metabolism. This study 
has verified a number of important findings regarding specific biological aspects of ifosfamide-induced hemor-
rhagic cystitis. We have expanded upon this body of work by defining multiple key pathogenetic mechanisms 
through comprehensive transcriptomics. Furthermore, our RNA-Seq data extends our prior work on the thera-
peutic effect of IPSE in ifosfamide-induced hemorrhagic cystitis24. This study has revealed a central role played by 
the IL-1β, TNFα and IL-6 triad in driving the substantial inflammation associated with ifosfamide-induced hem-
orrhagic cystitis18,23,41,42. A 100-fold increase in expression of Il1b, Tnfa and Il6 was reduced ~50% by pretreatment 
with a single dose of IPSE or a mutant of IPSE lacking the nuclear localization function (IPSE NLS mutant). We 
also confirmed that gene members of the heme hemostasis and oxidative stress response biological systems were 
highly transcribed following ifosfamide-induced hemorrhagic cystitis, presumably to restore antioxidants to nor-
mal levels27–31. The level of upregulation of these genes expressing antioxidant molecules were relatively lower in 
the IPSE group as compared to ifosfamide only group or IPSE NLS mutant group, indicating limiting effect of 
Figure 5. Effects of IPSE on bladder transcription of inflammation-related genes during ifosfamide-induced 
hemorrhagic cystitis. (A) Heat map showing levels of expression of genes encoding major proinflammatory 
proteins, their receptors, and downstream proinflammatory mediators and chemokines. Pretreatment with 
IPSE or its NLS mutant resulted in significant downregulation of genes encoding major proinflammatory 
proteins, their receptors, and downstream proinflammatory mediators and chemokines. Dotted line show 
downregulation in mice pretreated with IPSE or its NLS mutant. Red designates degrees of gene upregulation 
while blue denotes downregulation. The columns represent data for individual mice in each treatment group 
with “one minus Pearson correlation” method of hierarchical clustering (“Sal”: saline vehicle treatment, “Ifos”: 
ifosfamide treatment only, “ipse”: ifosfamide and IPSE treatment, “nls”: ifosfamide and IPSE NLS mutant 
treatment). (B) Schematic representation of the relationships among the IL-1β, TNFα and IL-6 triad and 
downstream pro-inflammatory cytokines and mediators. (C) A representative predicted mechanistic network, 
generated using IPA57, of gene interactions showing inhibitory relationships among chemokines (Ccl2), several 
interferon-induced proteins and nitric oxide synthase. Green color signifies directional gene expression that is 
part of dataset, passed the cut off values and downregulated. Orange color signifies directional gene expression 
that is part of dataset, passed the cut off values and upregulated. Gray color signifies gene expression that is 
part of dataset but unchanged. White color signifies genes that is not part of dataset. For other keys to the shape 
annotations, see description in Fig. 4.
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IPSE on oxidative stress. Thus, we have shown that these urotoxicity-associated transcriptional changes, especially 
inflammatory responses and to a less extent oxidative stress, were downregulated by IPSE when administered 
before ifosfamide challenge.
Unlike MESNA, which binds to and neutralizes acrolein directly to prevent urotoxicity, IPSE prevents or 
reverses the inflammatory changes that drive bladder damage following ifosfamide exposure. We postulate that 
IPSE, through its inhibitory transcriptional effects on IL-1β, TNFα and IL-6, key upstream cytokines driving 
inflammation via NFκB and STAT3, limits ifosfamide-triggered inflammation, urothelial denudation and vas-
cular pathogenesis. The ability of IPSE to induce gene expression of uroplakins24, crucial urothelial barrier func-
tion genes, is a likely contributor to IPSE’s therapeutic effect on the bladder following chemical insult48. Other 
candidate drugs for ifosfamide-induced hemorrhagic cystitis have also been shown to specifically target the 
IL-1β-TNFα-IL-6 pathway. Recombinant IL-4, quinovic acid glycosides, anakinra, diallyl disulfide and other 
anti-inflammatory candidates were separately shown to reduce the pathogenesis of hemorrhagic cystitis by inhi-
bition of the expression of these inflammatory cytokines and their receptors12,23,25,26. In accord with our observa-
tions, other drug studies have identified a therapeutic requirement for downregulation of IL-1β, TNFα and IL-6 
associated transcriptional factors (NFκB and STAT3)16,25 and downstream inflammatory mediators (iNOS and 
COX-2)12,16,41,42,49.
Besides effects on the IL-1β, TNFα and IL-6 triad, IPSE may also mediate critical gene expression changes 
in chemokines during ifosfamide-induced hemorrhagic cystitis. A range of major chemokines genes (Ccl2, Ccl3, 
Ccl4, Ccl5, Ccl7, Ccl12, Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl10 and Cxcl13) were significantly downregulated by pre-
treatment with either IPSE or its NLS mutant before ifosfamide insult. These chemokines act as chemo-attractants 
for immune cells to sites of inflammation during stress, tissue injury or infection. Notably, Cxcl10 transcription 
Figure 6. Most differentially altered gene expression pathways in bladders from IPSE-pretreated mice 
challenged with ifosfamide. Mice were pretreated with saline or IPSE, 24 hours before challenge with 400 mg/
kg of ifosfamide. The bladders were subjected to transcriptional profiling (RNA-Seq), followed by pathway 
and functional analyses generated using IPA57. Bars are colored according to z-score (predicts activation 
or inhibition based on the degree of overlap between directional expressions from observed data and the 
QIAGEN-curated public knowledge base), with red showing activation and blue denoting inhibition. The size of 
each bar is proportional to its –log(p-value).
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was upregulated in the bladder following ifosfamide insult, but was significantly decreased by comparison in 
IPSE-pretreated, ifosfamide-exposed bladders. Indeed, CXCL10 (interferon gamma-induced protein 10 - IP-10) 
blockade has been previously shown to significantly dampen cyclophosphamide-induced hemorrhagic cystitis50. 
Interleukin 8 receptor (Cxcr2) was also relatively downregulated by IPSE pretreatment before ifosfamide chal-
lenge. Notably, Cxcr2 was previously identified to play an important role in cyclophosphamide induced hemor-
rhagic cystitis51.
IPSE likely orchestrates a portion of its therapeutic effects through actions on other cytokines. Gene 
expression network analysis revealed a link between the observed downregulation of CCL2 in the bladders of 
IPSE-pretreated, ifosfamide-challenged mice (versus the bladders from mice receiving only ifosfamide) and 
several gamma interferon-inducible proteins. This coincides with the upregulation of CXCL10 (interferon 
gamma-induced protein 10 - IP-10) as well. Also, the interferon signaling pathway was the most downregu-
lated pathway in the bladders of IPSE-pretreated mice as compared to bladders only exposed to ifosfamide. Our 
results point to an association between downregulation of the interferon signaling pathway and amelioration of 
acrolein-induced urotoxicity, a mechanism that has not been previously linked to protection from hemorrhagic 
cystitis. The interferon signaling pathway has been previously shown to cross-talk with inflammasomes acti-
vated during inflammatory responses to irritants52,53. Some of these gamma interferon inducible genes are in 
turn linked to the development of pyroptosis, a highly inflammatory form of programmed cell death (Fig. 6B). 
Acrolein-induced pyroptotic cell death is a major determining factor of the severity of ifosfamide-induced uro-
toxicity5,16. Pyroptosis can be compounded by activation of the inflammasomes complex, which generates reac-
tive species which perpetuate a vicious cycle of cell death19. The ability of IPSE to downregulate the interferon 
pathway, in conjunction with downregulation of major inflammatory pathways, may limit inflammasomes acti-
vation and thus reduce acrolein-induced pyroptotic cell death. We hypothesize that IPSE, by bringing these pro-
cesses to heel, subsequently modulates downstream urothelial damage, hemorrhage, oxidative stress and cellular 
infiltration.
The therapeutic efficacy of IPSE in ifosfamide-induced hemorrhagic cystitis may also partially depend 
on its modulation of oxidative stress cascades. Acrolein is a potent inducer of oxidative stress17. Indeed, the 
NRF2-mediated oxidative stress responses pathway, which restores heme homeostasis and antioxidant responses, 
was highly expressed in the setting of ifosfamide-induced hemorrhagic cystitis46. Accordingly, Hmox1 and 
Slc7a11 were among the top upregulated genes from this transcriptomic analysis. Slc7a11 is a cysteine transporter, 
which has been implicated in glutathione metabolism in the bladder40. NRF2 induces the expression of heme oxy-
genase 1 (Hmox1), the first enzyme of the heme oxygenase pathway, and several antioxidant enzymes including 
glutathione reductase (Gsr), thioredoxin (Txn), thioredoxin reductase (Txnrd1), superoxide dismutase (Sod), 
peroxiredoxin 1 (Prdx1), ferritin light chain (Ftl1) and ferritin heavy chains (Fth1)20. An association between 
an increase in the expression of NRF2 and protection from ifosfamide-induced hemorrhagic cystitis is consist-
ent with a previous report linking hemostasis to reduction in hemorrhagic cystitis28,29,46. In addition, there is a 
Figure 7. Oxidative stress responses of the bladder during ifosfamide-induced hemorrhagic cystitis. 
Pathway and functional analyses were generated through the use of IPA57. (A) Schematic representation of 
the relationships between NRF2 and antioxidant proteins and proteins involved in heme homeostasis and 
xenobiotic detoxification. A more detailed version is shown in Supplementary Fig. S6. The keys to the shapes 
and colors are as detailed in Fig. 4. (B) Heat map showing levels of expression of genes encoding major 
antioxidant enzymes. Compared to the ifosfamide only group and group pretreated with the NLS mutant of 
IPSE, there were relative reduction in the expression of Abcc1, Gclc, Gclm, Gsr, Gss, Gsta1, Gsta2, Gm3776 and 
to some extent Prdx1, Stip1, Sod2, Dnaja1 and Dnajb1. Red designates gene upregulation while blue denotes 
downregulation. The columns represent data for individual mice in each treatment group without hierarchical 
clustering (“Sal”: saline vehicle treatment, “ipse”: ifosfamide and IPSE treatment, “nls”: ifosfamide and NLS 
mutant of IPSE treatment, “Ifos”: ifosfamide treatment only).
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strong pathophysiological relationship between inflammation and oxidative stress54. Severe pyroptosis can lead to 
enzymatic tissue damage and cellular DNA damage, which generate reactive species and superoxide radicals that 
induce oxidative stress5,54. When the bladder vasculature is exposed and injured following inflammation-driven 
urothelial damage, the resulting hemorrhage and release of heme further promotes oxidative stress. Based on the 
rationale that limiting inflammation reduces oxidative stress, and restoration of oxidative homeostasis initiates 
tissue repair processes, hemostatic agents and antioxidants have been widely tested as alternative therapies for 
preventing or reducing ifosfamide-induced hemorrhagic cystitis27–31,46. The link between inflammation and oxi-
dative stress is evident from findings that most antioxidants showing efficacy in ifosfamide-induced hemorrhagic 
cystitis also downregulate pro-inflammatory cytokines and their downstream mediators29,31. In the same vein, 
anti-inflammatory drug candidates with efficacy in ifosfamide-induced hemorrhagic cystitis can also restore anti-
oxidant enzyme activity to homoeostatic levels25.
In this study in relation to the foregoing, we observe relative transcriptional downregulation in oxidative 
stress responses by IPSE pretreatment but not for pretreatment with the NLS mutant of IPSE. It was interesting 
to observe that the gene encoding the proteins involved in iron homeostasis (Fth1) was relatively restored to 
baseline in bladders from the IPSE treated group. Also, genes encoding some antioxidant proteins involved in 
xenobiotic detoxification and hemostasis (Gclm, Gclc, Gsr, Gss, Gsta1, Gsta2 and Gm3776), superoxide detoxi-
fication (Sod2) and stress induced chaperones (Stip1, Dnaja1 and Dnajb1) were also reduced in bladders from 
the IPSE-pretreated group but not in the ifosfamide only or IPSE NLS mutant group. In addition, gene encod-
ing the multidrug resistance protein 1 (Abcc1, Mrp1), which functions as an anion transporter with glutathione 
as a substrate55, returned to basal levels in the ifosfamide-exposed bladder following IPSE pretreatment. Taken 
together, these differences suggest reduced levels of oxidative stress are present in ifosfamide-exposed bladders 
from IPSE-pretreated group, evident in reduced levels of genes related to detoxification of xenobiotics, DNA 
damage sensing, hemostasis and iron homeostasis. Although the IPSE NLS mutant lacking the nuclear localiza-
tion function partially downregulated inflammation, it did not show similar level of downregulation of oxidative 
stress. The ability to translocate into the nucleus arms IPSE with important transcriptional modulatory property 
which may be limited for the NLS mutant. However, this mutant of IPSE potentially still retains its other extracel-
lular and extra-nuclear functions.
Ifosfamide injury of the bladder may disrupt homeostasis of pathways besides oxidative stress. The PPAR 
pathway was downregulated in the ifosfamide-exposed bladder, which would presumably impair restoration of 
lipid homeostasis following epithelial membrane damage by acrolein. The PPAR pathway is also a modulator 
of inflammatory responses43,44 in addition to its role in the development and maintenance of IL-4 dependent 
alternatively activated status in macrophages45, which we speculate may be inhibited in the highly inflammatory 
environment of the ifosfamide-injured bladder. Interestingly, relative to the ifosfamide only group, we observe 
upregulatory effect of IPSE pretreatment on transcription of gene members of the PPAR pathway. The most 
IPSE-downregulated genes in the ifosfamide-exposed bladder were those related to the neuro-inflammation sig-
naling pathway (specifically, pathways active in central nervous system cells, i.e., astrocytes and microglia). We 
have previously reported that IPSE alleviates ifosfamide-induced bladder pain by assessment of allodynia24. It 
remains to be shown whether this observed downregulation of neuro-inflammatory signaling is directly linked to 
this protective effect on allodynia, especially given the absence of astrocytes and microglia in the bladder.
While this study has revealed potential mechanistic changes associated with ifosfamide-induced hem-
orrhagic cystitis, and presented evidence of possible underlying mechanisms of IPSE’s therapeutic effect, our 
RNA-Seq-based approach cannot establish a causal relationship between observed gene expression and phe-
nomena of interest (including IPSE’s therapeutic effects). Given that pretreatment with the NLS mutant of IPSE 
partially downregulated inflammation as wildtype IPSE but not oxidative stress different from wild type IPSE, 
this dataset did not completely elucidate whether the therapeutic effects of IPSE are due to its IL-4-inducing 
properties, chemokine sequestration, or nuclear translocation-related direct transcriptional effects. However, 
there is indication that the NLS function is at least required for the effect of IPSE on oxidative homoeostasis. The 
downregulation of interferon signaling and its related genes is intriguing, but it is unclear to which extent this can 
be ascribed to IPSE-induced IL-4. Also, RNA-Seq does not capture epigenetic or post-translational regulation of 
gene or protein expression and activity. Moreover, we focused on a single, early time point following ifosfamide 
exposure. Although we observed differential transcription of multiple genes of interest at this time point, it is 
unlikely that this cross-sectional analysis has captured all relevant gene expression changes. For instance, IPSE 
in the context of being the most abundant schistosomes secreted protein is the major driver of Th2 response, 
however, this early time point study design has focused on only non-T-cell, non-B-cell sources of IPSE-induced 
IL-4 release36,56. Further studies may be required to show whether similar therapeutic effect will be observed when 
the adaptive response sources of IL-4 are involved. Finally, this study focused on transcriptional changes in the 
bladder alone and did not examine systemic gene expression induced by ifosfamide and IPSE. It is possible that 
such gene expression may account for some of ifosfamide and IPSE’s in vivo effects.
In conclusion, we have elucidated transcriptional dynamics associated with ifosfamide-induced hemor-
rhagic cystitis. These data provide new insights into the underlying mechanisms driving acrolein-induced 
urotoxicity associated with the use of ifosfamide and other oxazaphosphorines. We also showed that IPSE, an 
anti-inflammatory, parasite-derived molecule with therapeutic potential for ifosfamide-induced hemorrhagic 
cystitis24, downregulates major inflammatory pathways and to some extent oxidative stress, potentially related 
to its mechanisms of effect. Our work demonstrates that there may be therapeutic potential for naturally occur-
ring anti-inflammatory molecules, including pathogen-derived factors, as alternative or complementary thera-
pies for ifosfamide-induced hemorrhagic cystitis. Apart from inhibition of inflammation and modest restoration 
of normal levels of antioxidants by IPSE but not its NLS mutant, we did not observe complete prevention of 
acrolein-induced oxidative stress by IPSE pretreatment. This is probably due to IPSE’s inability to directly bind to 
and neutralize acrolein (the mechanism of MESNA). Thus, IPSE is playing only a limited role on oxidative stress 
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while suppressing inflammation. However, we have only compared one dose of IPSE given before ifosfamide 
challenge against three doses of MESNA24. It remains to be shown whether IPSE will produce more ameliorative 
effects when given in multiple doses or through alternative routes. Ongoing work is focusing on optimization of 
IPSE, specifically related to its IL-4 induction and chemokine binding properties, to enhance its efficacy while 
preventing toxicity. Our hope is that these variations on IPSE and its administration will result in significantly 
improved efficacy, and ultimately, an alternative to MESNA in preventing ifosfamide-induced hemorrhagic 
cystitis.
Materials and Methods
ethical approval. Animal experiments reported in this study were conducted in a humane manner, adhering 
to relevant U.S. and international guidelines. Our animal handling and experimental protocols were reviewed and 
approved by the Institutional Animal Care and Use Committee (IACUC) of the Biomedical Research Institute, 
Rockville, Maryland, USA. Our IACUC guidelines comply with the U.S. Public Health Service Policy on Human 
Care and Use of Laboratory Animals.
Animals, reagents and drugs. Female 7-week-old C57BL/6 mice (Charles River Laboratories, 
Wilmington, MA, USA) were housed using 12-h light-dark cycles in temperature-controlled holding rooms, with 
an unlimited supply of dry mouse chow and water. Ifosfamide (>98% purity) was purchased from Sigma-Aldrich 
(Sigma-Aldrich, St. Louis, MO, USA). IPSE cloning, expression and purification was performed as previously 
described24,38.
Ifosfamide-induced hemorrhagic cystitis model. The ifosfamide-induced hemorrhagic cystitis model 
presented in this study was performed following methods previously described by Macedo et al.12. Mice were 
intravenously injected with 25 μg of either IPSE or a mutant of IPSE lacking the nuclear localization sequence 
(IPSE NLS mutant) or saline 24 hours before intraperitoneal ifosfamide injection (400 mg/kg). Mice were then 
monitored for 6 hours post-ifosfamide injection before they were sacrificed for downstream experiments. 
Bladders were aseptically collected for RNA purification.
RNA purification. RNA was isolated from mouse bladders using TRIzol Reagent and PureLink RNA Mini Kit 
(Invitrogen), according to manufacturers’ instructions. Briefly, aseptically excised bladders were homogenized in 
1 ml TRIzol Reagent by bead-beating using ceramic beads (Omni International) and a mini-bead beater (Biospec). 
Following a 5-min incubation, 0.2 ml chloroform was added and again incubated for 3 min before centrifugation at 
12,000 × g for 15 min to separate homogenates into aqueous and organic phases. The aqueous supernatant (~400ul) 
was mixed with an equal volume of 70% ethanol before binding the mixture to RNA binding columns by centrifuga-
tion. On-column DNase digestion (Invitrogen) was performed for 30 minutes, following the manufacturer’s proto-
cols. After column washes and drying, RNA was eluted in RNase-free water, quantified and its quality checked using 
a NanoDrop 1000 spectrophotometer (Thermo Scientific) and Bioanalyzer 2100 (Agilent).
RNA sequencing and RNA-seq analysis pipeline. RNA sequencing was performed using the 
Illumina-HiSeq. 4000 NGS platform at a depth of >20 million reads. Analyses were conducted using the RNA 
analysis tools of the Galaxy platform (www.usegalaxy.org). Raw sequence reads were aligned to the mouse 
genome (Mm10) by HISAT2. The resulting alignment files, along with the corresponding mouse genome annota-
tion file, were used as the input for HTSeq-count. DESeq. 2 was used to determine differentially expressed genes 
between each pair of treatment groups. PCA plots were also generated by DESeq. 2. The DESeq. 2 results files 
containing gene IDs, log2 fold change and standard deviation, p-values and adjusted p-values were processed 
further downstream for functional analysis.
Functional and pathway analysis, statistics and plots. Pathway, mechanistic network and functional 
analyses were generated through the use of IPA (QIAGEN Inc., https://www.qiagenbio- informatics.com/products/
ingenuity-pathway-analysis)57. The threshold cut-off was set at p-value (adjusted) <0.1 for gene expression compar-
isons between bladders exposed to ifosfamide versus saline vehicle, and p-value < 0.05 for gene expression compari-
sons between IPSE-pretreated, ifosfamide-exposed bladders versus bladders only exposed to ifosfamide. The cut off 
for log2(fold change) was set at >1 (2 fold). The heatmaps were generated using the Morpheus program from Broad 
Institute. Other data analyses and plots were generated using GraphPad Prism v 6.00, and ggplot2 and plotly packages 
in R. For comparisons among groups, one way analysis of variance (ANOVA) was performed and if significant, was 
followed by post hoc Student t-tests for pairwise comparisons after confirming a normal distribution. Plotted data 
show individual data points with error bars representing means and standard deviation.
Histology. Bladders were fixed in 10% neutral-buffered formalin and later dehydrated and embedded in par-
affin. Paraffin-embedded bladders were cut into 5 micron sections and then processed for hematoxylin and eosin 
staining. The stained sections were evaluated microscopically (in a blinded fashion by J.I.O.) for the presence of 
urothelial denudation, lamina propria edema, hemorrhage, and cellular infiltration.
Data Availability
All raw and analyzed data are readily available on request.
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